16-30 of 696
Understanding Crossover and Endpoints in ASCENT-03 and -04
Project Oncology®Understanding Crossover and Endpoints in ASCENT-03 and -04
Jennifer Caudle, DO, FACOFP
Neil M. Iyengar, MD
Improving Pain Management During Intrauterine Device Insertion
Advances in Women's HealthImproving Pain Management During Intrauterine Device Insertion
Alexandria May, PharmD, BCPS
Mitchell D. Creinin, MD
Managing Perimenopausal Bleeding with Evidence-Based Options
Advances in Women's HealthManaging Perimenopausal Bleeding with Evidence-Based Options
Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Monica Christmas, MD
Mary Jane Minkin, MD
Menopause Reimagined: The Role of Hormonal IUDs in Perimenopausal Care
Advances in Women's HealthMenopause Reimagined: The Role of Hormonal IUDs in Perimenopausal Care
Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Mary Jane Minkin, MD
How the First Metastatic Site Shapes Survival in Breast Cancer Relapse
Project Oncology®How the First Metastatic Site Shapes Survival in Breast Cancer Relapse
Ryan Quigley
Applying Real-World Data from SABCS 2025 to HR+ HER2- Breast Cancer Care
Project Oncology®Applying Real-World Data from SABCS 2025 to HR+ HER2- Breast Cancer Care
Pavani Chalasani, MD, MPH
Virginia Borges, MD
- advertisement
Longitudinal Biopsies in mBC Map Immune Response to HER2 Tri-Blockade
Project Oncology®Longitudinal Biopsies in mBC Map Immune Response to HER2 Tri-Blockade
What Rapid Autopsies Reveal About Metastatic Breast Cancer Biology
Project Oncology®What Rapid Autopsies Reveal About Metastatic Breast Cancer Biology
Predicting Breast Cancer Metastasis with Proteomics
Project Oncology®Predicting Breast Cancer Metastasis with Proteomics
HER2-Positive Breast Cancer and the Challenge of Brain Metastases
On the Frontlines of Metastatic Breast CancerHER2-Positive Breast Cancer and the Challenge of Brain Metastases
Charles Turck, PharmD, BCPS, BCCCP
Heather Parsons
Tracking Early Immunotherapy Response in mTNBC Using cfDNA-Based Copy-Number Profiling
Project Oncology®Tracking Early Immunotherapy Response in mTNBC Using cfDNA-Based Copy-Number Profiling
- advertisement
The Next Chapter: SABCS 2025 and the Future of HR+ HER2− Breast Cancer Care
Project Oncology®The Next Chapter: SABCS 2025 and the Future of HR+ HER2− Breast Cancer Care
Pavani Chalasani, MD, MPH
Alison Stopeck, MD
How ctDNA and Liquid Biopsy Are Shaping Early Detection of Breast Cancer Progression
On the Frontlines of Metastatic Breast CancerHow ctDNA and Liquid Biopsy Are Shaping Early Detection of Breast Cancer Progression
Ashley Baker, MSN, PMHNP
Nick McAndrew, MD, MSCE
Exploring T-DXd in HER2-Positive Breast Cancer Treatment
On the Frontlines of Metastatic Breast CancerExploring T-DXd in HER2-Positive Breast Cancer Treatment
Charles Turck, PharmD, BCPS, BCCCP
Jules Cohen, MD
